Michele Baptista

Senior Director of Business Development

Michele Baptista brings extensive industry knowledge to Sabai, having worked within the ethics and regulatory review sector for more than 30 years. During that time Michele co-founded Aspire IRB and held various Operational and Commercial responsibilities until Aspire was acquired by WCG in 2014. Michele remained at WCG for almost 20 years before departing for a role within the CenExel site network, prior to joining us at Sabai. Michele was among the first 100 individuals in the country to become a Certified IRB Professional, a designation she has held for 20+ years. Michele is well known to many Sabai employees, brings extensive industry knowledge and strong West Coast connections, and was also responsible for promoting Sabai services when she was at Cenexel.

Michele is based in the San Diego area. When she’s not working, Michele is an avid fan of all things Disney, riding eBikes, and the cheering on the San Diego Padres.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.